CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
Nat Commun. 2019 Feb 4;10(1):558. doi: 10.1038/s41467-018-06958-9.
Nat Commun. 2019.
PMID: 30718512
Free PMC article.